PRPO - Precipio, Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
New Haven,
United States
Type: Equity
PRPO price evolution
PRPO
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1.28 | $0.78 | $1.5 | |
| Short term investments | ||||
| Net receivables | $1.02 | $1.11 | $0.91 | $1.3 |
| Inventory | $0.59 | $0.65 | $0.53 | $0.38 |
| Total current assets | $3.25 | $3.36 | $2.6 | $3.68 |
| Long term investments | ||||
| Property, plant & equipment | $1.54 | $1.55 | $1.38 | $1.52 |
| Goodwill & intangible assets | $12.34 | $12.58 | $12.82 | |
| Total noncurrent assets | $13.95 | $14.03 | $14.42 | |
| Total investments | ||||
| Total assets | $16.95 | $17.32 | $16.62 | $18.1 |
| Current liabilities | ||||
| Accounts payable | $0.7 | $0.85 | $0.91 | $0.62 |
| Deferred revenue | $0.26 | $0.19 | $0.11 | |
| Short long term debt | $0.56 | $0.41 | $0.58 | |
| Total current liabilities | $4.48 | $4.59 | $3.33 | $3.14 |
| Long term debt | $0.27 | $0.61 | $0.52 | $0.53 |
| Total noncurrent liabilities | $0.61 | $0.52 | $0.53 | |
| Total debt | $1.17 | $0.93 | $1.12 | |
| Total liabilities | $5.01 | $5.2 | $3.85 | $3.67 |
| Shareholders' equity | ||||
| Retained earnings | -$102.08 | -$101.45 | -$100.23 | -$98.15 |
| Other shareholder equity | ||||
| Total shareholder equity | $12.12 | $12.77 | $14.43 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1.5 | $3.44 | $11.67 | $2.66 |
| Short term investments | ||||
| Net receivables | $1.3 | $1.04 | $0.7 | $0.87 |
| Inventory | $0.38 | $0.71 | $0.56 | $0.35 |
| Total current assets | $3.68 | $5.71 | $13.48 | $4.2 |
| Long term investments | ||||
| Property, plant & equipment | $1.52 | $1.9 | $2.06 | $0.79 |
| Goodwill & intangible assets | $12.82 | $13.77 | $14.72 | $15.67 |
| Total noncurrent assets | $14.42 | $15.79 | $16.96 | $16.51 |
| Total investments | ||||
| Total assets | $18.1 | $21.5 | $30.44 | $20.71 |
| Current liabilities | ||||
| Accounts payable | $0.62 | $2.04 | $1.86 | $1.69 |
| Deferred revenue | $0.11 | $0.12 | $0.02 | $0.01 |
| Short long term debt | $0.58 | $0.62 | $0.41 | $0.92 |
| Total current liabilities | $3.14 | $4.36 | $4.21 | $4.66 |
| Long term debt | $0.53 | $0.2 | $1.02 | $0.57 |
| Total noncurrent liabilities | $0.53 | $0.78 | $1.62 | $1.9 |
| Total debt | $1.12 | $1.39 | $1.43 | $1.49 |
| Total liabilities | $3.67 | $5.2 | $5.83 | $6.55 |
| Shareholders' equity | ||||
| Retained earnings | -$98.15 | -$92.3 | -$80.09 | -$71.56 |
| Other shareholder equity | $0.03 | |||
| Total shareholder equity | $14.43 | $16.3 | $24.56 | $14.13 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5.21 | $4.44 | $3.43 | $4.33 |
| Cost of revenue | $2.73 | $2.51 | $2.32 | |
| Gross Profit | $2.28 | $1.72 | $0.92 | $2.01 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2.92 | $2.99 | $2.87 | |
| Total operating expenses | $2.87 | $2.92 | $2.99 | $2.87 |
| Operating income | -$1.21 | -$2.07 | -$0.85 | |
| Income from continuing operations | ||||
| EBIT | -$1.21 | -$2.07 | $0.93 | |
| Income tax expense | ||||
| Interest expense | -$0.03 | $0.01 | $0.01 | $0.01 |
| Net income | ||||
| Net income | -$0.63 | -$1.22 | -$2.08 | $0.93 |
| Income (for common shares) | -$1.22 | -$2.08 | $0.93 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $15.2 | $9.41 | $8.85 | $6.09 |
| Cost of revenue | $9.18 | $6.9 | $6.46 | $4.94 |
| Gross Profit | $6.02 | $2.51 | $2.39 | $1.15 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $13.64 | $15.31 | $12.01 | $10.3 |
| Total operating expenses | $13.64 | $15.31 | $12.01 | $10.3 |
| Operating income | -$7.62 | -$12.8 | -$9.61 | -$9.15 |
| Income from continuing operations | ||||
| EBIT | -$5.83 | -$12.19 | -$8.51 | -$10.15 |
| Income tax expense | ||||
| Interest expense | $0.02 | $0.01 | $0.02 | $0.47 |
| Net income | ||||
| Net income | -$5.85 | -$12.2 | -$8.53 | -$10.63 |
| Income (for common shares) | -$5.85 | -$12.2 | -$8.53 | -$13.97 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$1.22 | -$2.08 | $0.93 | |
| Operating activities | ||||
| Depreciation | $0.37 | $0.38 | $0.37 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.3 | $0.36 | $0.39 | |
| Total cash flows from operations | $0.5 | -$0.67 | $0.11 | |
| Investing activities | ||||
| Capital expenditures | -$0.07 | -$0.05 | ||
| Investments | ||||
| Total cash flows from investing | -$0.18 | -$0.07 | -$0.05 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.01 | $0.07 | ||
| Net borrowings | $0.09 | -$0.13 | -$0.13 | |
| Total cash flows from financing | -$0.14 | $0.07 | -$0.06 | -$0.13 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$0.45 | $0.5 | -$0.73 | -$0.06 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$5.85 | -$12.2 | -$8.53 | -$10.63 |
| Operating activities | ||||
| Depreciation | $1.52 | $1.52 | $1.44 | $1.36 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.56 | $3.8 | $1.88 | $0.7 |
| Total cash flows from operations | -$3.56 | -$7.72 | -$6.58 | -$7.43 |
| Investing activities | ||||
| Capital expenditures | -$0.13 | -$0.28 | -$0.68 | -$0.1 |
| Investments | ||||
| Total cash flows from investing | -$0.13 | -$0.28 | -$0.68 | -$0.1 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.25 | $0.14 | $16.61 | $8.93 |
| Net borrowings | -$0.5 | -$0.36 | -$0.17 | $0.41 |
| Total cash flows from financing | $1.74 | -$0.23 | $16.27 | $9.34 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$1.94 | -$8.22 | $9.01 | $1.81 |
News
Fundamentals
| Market cap | $36.71M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 1.48M |
| Revenue | $17.41M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$3.00M |
| Revenue Q/Q | 15.29% |
| Revenue Y/Y | 31.31% |
| P/E ratio | -12.24 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.11 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$2.02 |
|---|---|
| ROA | -17.39% |
| ROE | N/A |
| Debt/Equity | 0.25 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.73 |
| Quick ratio | 0.60 |